FDA Panel To Decide Whether New Breast, Prostate Cancer Drugs Are Worth The Risks

Summaries of health policy coverage from major news organizations Wednesday, Apr 29 2026 9:06 AM Full Issue FDA staff have expressed concerns about the use of camizestrant to treat metastatic breast cancer and capivasertib for patients with metastatic hormone-sensitive prostate cancer. The Oncologic Drugs Advisory Committee will vote on these two drug applications Thursday. MedPage…

Read Full News

3 Drugs On Horizon Could Help Lower Lp(a), A Genetic Form Of Cholesterol That Raises Heart Attack Risk

Summaries of health policy coverage from major news organizations Tuesday, Apr 28 2026 Full Issue At least three pharma firms — Novartis, Amgen, and Eli Lilly — say they’re closer to unraveling the mystery of lipoprotein(a), which is a more dangerous cousin to LDL cholesterol. Diet and exercise don’t influence lp(a) levels, CNBC reported, and…

Read Full News

Nuevas reglas federales de Medicaid exigen un mes de trabajo. Algunos estados piden más

Samantha Liss Millones de personas que soliciten Medicaid en los próximos años tendrán que demostrar que han estado trabajando, estudiando o haciendo voluntariado durante al menos un mes antes de poder obtener o conservar este seguro de salud federal que gerencian los estados. Pero legisladores republicanos en algunos estados creen que las nuevas reglas —parte…

Read Full News